Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis
NCT05889572
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis
ALS
Interventions
DRUG:
MaaT033
Sponsor
MaaT Pharma